Benkert O, Horn K, Pickardt C R, Schmid D
Arch Sex Behav. 1976 Jul;5(4):269-74.
Thyrotropin-releasing factor was given orally to 12 impotent patients in a dose of 43 mg daily for 4 weeks in a double-blind crossover technique and compared with placebo. TRF showed no beneficial effect over placebo. In these patients, thyroid function and the hypothalamic-pituitary-thyroid axis were examined by measuring T3, T4, and TSH before and after the TRF test. There were no pathological findings for patients included in this study.
采用双盲交叉技术，对12例阳痿患者口服促甲状腺素释放因子，剂量为每日43毫克，持续4周，并与安慰剂进行比较。促甲状腺素释放因子与安慰剂相比未显示出有益效果。对这些患者在促甲状腺素释放因子试验前后通过测量T3、T4和促甲状腺激素来检查甲状腺功能及下丘脑-垂体-甲状腺轴。本研究纳入的患者未发现病理结果。
